Skip to main content
Fig. 3 | Immunity & Ageing

Fig. 3

From: B-1 derived anti-Thy-1 B cells in old aged mice develop lymphoma/leukemia with high expression of CD11b and Hamp2 that different from TCL1 transgenic mice

Fig. 3

Nod1 is important in early B1a cells and Nod1, IL-5R, CD1d decrease in old aged and increased CD11b and CXCR4, different from middle aged TC+Tg ATA B cells. A Nod1 high in neonate and adult B1a. 2 mo FO B versus pB1a for ZAP70 generation after 20 hour later by anti-IgM without or with CiE–DAP (Nod1) or MDF (Nod2), or TNFa without or with CiE-DAP. ZAP70hi in a-IgM is only FO B cells not CD5+pB1a, but Nod1 add increased ZAP70. Down: 4 mo ATAμκ Tg mice with NOD1+/– or NOD1–/–. ATAid is originally generated VH8-12/VK21-5, then, low ATA B cells in Nod1–/–. Thus, Nod1 is important. B Nod1, IL-5R, CD1d comparison between TC– versus TC+Tg ATAμκTg, in 2 mo and meddle aged leukemia CLL and old aged TC– CLL/lymphoma. Old aged TC– tumor showed down these lists, not middle aged TC– and TC+Tg. C Conclution of TC–ATAμκTg ATA B in 2 mo verus old age tumor stage in spleen, with increased CD11b in TC– ATA B in flow cytometry analysis. Down: In microarray analysis, TC– old age ATA B cells are CXCR4 increase versus CXCR5 down, different compared with TC+Tg. Down right: Several TC– versus TC+Tg ATAuk Tg lymphoma/leukemia pictures used for Fig. 4: 16 mo and 17 mo TC–ZAP70–CD5– (Spl++, mLM++, LN+), 22 mo TC–ZAP70+CD5+ (Spl++, colon++, LN+), 10 mo TC+ZAP70–CD5+ (Spl++, mLN+, PerC++), 16 mo TC+ZAP70+CD5+ (Spl++, Liver++, PerC++), and 12 mo samples Fig. 5

Back to article page